2023 Nov 21;9(1):28
A large-scale study involving over 2,400 patients with type 2 diabetes found that the majority of participants who began GLP-1 agonist treatment experienced weight loss over a 72-week period
Kaufman reported that after embracing doctors and patients reports and launching the trial, RECOVER is not following ME/CFS and long-COVID doctors experience when it comes to running the trial
Analysis of application in patients with digestive system diseases BPC 157 (Body Protection Compound 157) is a synthetic peptide composed of 15 amino acids, which has significant gastrointestinal protection, anti-inflammatory and tissue repair properties
~ AlphaMD When your doctor orders blood work, its normal to wonder how long the process will take from the moment you sit down in the lab chair to when you finally get your results
It is being investigated in research settings for its role in energy homeostasis, lipid metabolism, and glucose regulation